Clinical immunology (Orlando, Fla.) · 2020
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gao Chun, Zhu Li, Jin Cheng Cheng, Tong Yi Xin, Xiao Ai Tang, Zhang Sheng
Аннотация
Since December 2019, Coronavirus Disease 2019 (COVID-19) has emerged as a global pandemic. We aimed to investigate the clinical characteristics and analyzed the risk factors for prolonged viral RNA shedding. We retrospectively collected data from 112 hospitalized COVID-19 patients in a single center in Wuhan, China. Factors associated with prolonged viral RNA shedding (≥28 days) were investigated. Forty-nine (43.8%) patients had prolonged viral RNA shedding. Patients with prolonged viral shedding were older and had a higher rate of hypertension. Proinflammatory cytokines, including interleukin-2R (IL-2R) and tumor necrosis factor-α (TNF-α), were significantly elevated in patients with prolonged viral shedding. Multivariate analysis revealed that hypertension, older age, lymphopenia and elevated serum IL-2R were independent risk factors for prolonged viral shedding. This comprehensive investigation revealed the distinct characteristics between patients with or without prolonged viral RNA shedding. Hypertension, older age, lymphopenia and high levels of proinflammatory cytokines may be correlated with prolonged viral shedding.
Предметные рубрики MeSH
Adrenal Cortex HormonesAdultAgedAged, 80 and overCOVID-19ChinaComorbidityCytokine Release SyndromeDiabetes MellitusDrug CombinationsFemaleHospitalizationHumansHydroxychloroquineHypertensionInterferonsLopinavirLymphopeniaMaleMiddle AgedRNA, ViralReceptors, Interleukin-2Retrospective StudiesRisk FactorsRitonavirSARS-CoV-2Severity of Illness IndexTumor Necrosis Factor-alphaVirus SheddingCOVID-19 Drug Treatment